Author

S. Nair

Institution: Janssen (Belgium)

Observed institution: Janssen (Belgium)

OpenAlex ID: A5031616625

P899: Real-world Assessment of Treatment Patterns and Outcomes in Patients With Lenalidomide-refractory Relapsed/refractory Multiple Myeloma From the Optum Database

2022 · B. Dhakal, H. Einsele, et al. · HemaSphere · 9

EP08.02-016 Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs

2022 · N. Girard, B. Besse, et al. · Journal of Thoracic Oncology · 1

Works count: 2

Citation count: 10

H-index: 1

I10-index: